D. E. Shaw & Co., Inc. Aclaris Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$122 Billion
Q4 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Aclaris Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 3,293,625 shares of ACRS stock, worth $6.09 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,293,625

Previous 3,371,849 2.32%

Holding current value

$6.09 Million

Previous $3.81 Million 114.38%

% of portfolio

0.01%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$1.15 - $4.59 $89,957 - $359,048	-78,224 Reduced 2.32%	3,293,625 $8.17 Million
Q3 2024 Nov 14, 2024	BUY	$1.12 - $1.4 $57,840 - $72,300	51,643 Added 1.56%	3,371,849 $3.81 Million
Q2 2024 Aug 14, 2024	BUY	$1.01 - $1.36 $37,596 - $50,624	37,224 Added 1.13%	3,320,206 $3.65 Million
Q1 2024 May 15, 2024	BUY	$0.92 - $1.44 $1.24 Million - $1.94 Million	1,343,972 Added 69.31%	3,282,982 $4.07 Million
Q4 2023 Feb 14, 2024	BUY	$0.64 - $6.49 $1.2 Million - $12.2 Million	1,873,000 Added 2837.45%	1,939,010 $2.04 Million
Q3 2023 Nov 14, 2023	BUY	$6.56 - $10.95 $243,290 - $406,102	37,087 Added 128.23%	66,010 $452,000
Q2 2023 Aug 14, 2023	BUY	$7.89 - $10.64 $228,202 - $307,740	28,923 New	28,923 $299,000
Q1 2022 May 16, 2022	SELL	$9.74 - $17.92 $222,695 - $409,722	-22,864 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$12.27 - $18.49 $500,100 - $753,615	-40,758 Reduced 64.06%	22,864 $332,000
Q3 2021 Nov 15, 2021	SELL	$13.38 - $18.8 $2.75 Million - $3.87 Million	-205,633 Reduced 76.37%	63,622 $1.15 Million
Q2 2021 Aug 16, 2021	BUY	$17.08 - $29.6 $4.6 Million - $7.97 Million	269,255 New	269,255 $4.73 Million
Q1 2020 May 15, 2020	SELL	$0.75 - $2.18 $52,326 - $152,096	-69,769 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$1.02 - $1.97 $644,329 - $1.24 Million	-631,696 Reduced 90.05%	69,769 $132,000
Q3 2019 Nov 14, 2019	BUY	$0.79 - $2.47 $25,442 - $79,548	32,206 Added 4.81%	701,465 $758,000
Q2 2019 Aug 14, 2019	SELL	$2.13 - $7.06 $2.52 Million - $8.36 Million	-1,183,610 Reduced 63.88%	669,259 $1.47 Million
Q1 2019 May 15, 2019	SELL	$5.63 - $7.84 $2.4 Million - $3.34 Million	-425,495 Reduced 18.68%	1,852,869 $11.1 Million
Q4 2018 Feb 14, 2019	BUY	$6.3 - $15.4 $5.99 Million - $14.6 Million	950,781 Added 71.62%	2,278,364 $16.8 Million
Q3 2018 Nov 14, 2018	BUY	$14.38 - $20.89 $843,645 - $1.23 Million	58,668 Added 4.62%	1,327,583 $19.3 Million
Q2 2018 Aug 14, 2018	BUY	$16.46 - $20.33 $504,153 - $622,687	30,629 Added 2.47%	1,268,915 $25.3 Million
Q1 2018 May 15, 2018	BUY	$17.08 - $25.64 $3.67 Million - $5.52 Million	215,158 Added 21.03%	1,238,286 $21.7 Million
Q4 2017 Feb 14, 2018	BUY	$21.47 - $27.8 $21.7 Million - $28.1 Million	1,010,970 Added 8315.27%	1,023,128 $25.2 Million
Q3 2017 Nov 14, 2017	BUY	$23.02 - $28.8 $279,877 - $350,150	12,158	12,158 $314,000

Others Institutions Holding ACRS

# of Institutions

106

Shares Held

87.8M

Call Options Held

293K

Put Options Held

124K

View Full List

About Aclaris Therapeutics, Inc.

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $123M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

More about ACRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account